We are live on ! Find out more
FCSC

Fibrocell Science Inc.
FCSC

Delisted

FCSC was delisted on the 12th of December, 2019.

46 hedge funds and large institutions have $142M invested in Fibrocell Science Inc. in 2014 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

75% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 4

64% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 11

37% more capital invested

Capital invested by funds: $103M → $142M (+$38.8M)

7% more funds holding

Funds holding: 4346 (+3)

Holders
46
Holders Change
+3
Holders Change %
+6.98%
% of All Funds
1.33%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
7
Increased
18
Reduced
11
Closed
4
Calls
$81K
Puts
Net Calls
+$81K
Net Calls Change
+$80K
Name Holding Trade Value Shares
Change
Change in
Stake
TS
1
Third Security
Virginia
$79.7M +$5.3M +68,306 +7%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$18.9M
Jennison Associates
3
Jennison Associates
New York
$15.5M +$84.6K +1,091 +0.6%
MP
4
MSD Partners
New York
$9.04M -$302K -3,891 -3%
BFA
5
BlackRock Fund Advisors
California
$3.29M +$142K +1,834 +5%
Vanguard Group
6
Vanguard Group
Pennsylvania
$2.71M +$615K +7,938 +30%
BGA
7
Belmont Global Advisors
Texas
$2.46M +$1.14M +14,646 +88%
State Street
8
State Street
Massachusetts
$1.51M +$477K +6,157 +47%
Northern Trust
9
Northern Trust
Illinois
$1.15M -$54.6K -704 -5%
BIT
10
BlackRock Institutional Trust
California
$1.08M +$11.9K +153 +1%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$904K +$58K +748 +7%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$721K +$239K +3,085 +50%
BCM
13
Bridgeway Capital Management
Texas
$633K +$625K +8,067 New
HVC
14
Healthcare Value Capital
New Jersey
$564K +$557K +7,185 New
Citigroup
15
Citigroup
New York
$447K -$37.3K -481 -8%
TCIM
16
TIAA CREF Investment Management
New York
$436K
SC
17
Saiers Capital
New York
$370K
FSA
18
Franklin Street Advisors
North Carolina
$361K +$263K +3,397 +283%
BIM
19
BlackRock Investment Management
Delaware
$327K +$13.6K +175 +4%
TMC
20
Trellus Management Company
Florida
$224K +$221K +2,853 New
Goldman Sachs
21
Goldman Sachs
New York
$218K -$930 -12 -0.4%
California State Teachers Retirement System (CalSTRS)
22
California State Teachers Retirement System (CalSTRS)
California
$211K
SIP
23
Stoneridge Investment Partners
Pennsylvania
$158K -$143K -1,849 -48%
TA
24
Teachers Advisors
New York
$154K
EEG
25
E.E. Geduld
$131K -$51.6K -666 -29%

FCSC Hedge Fund Activity: Q1 2014 in Review

46 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q1 2014, worth a combined $142M — up 37% from $103M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new FCSC positions and 4 closed out — a net gain of 3 holders — while 18 added to existing stakes and 11 trimmed.

The largest buyer was Third Security, adding an estimated $5.3M. The largest seller was Sabby Management, exiting entirely with an estimated $363K sold.

  • 46 institutional investors held Fibrocell Science Inc. (FCSC) as of Q1 2014, up from 43 in Q4 2013.
  • Funds reported $142M of Fibrocell Science Inc. stock for Q1 2014, up 37% quarter-over-quarter.
  • 7 funds opened new Fibrocell Science Inc. positions in Q1 2014 and 4 closed out, a net change of +3 holders.
  • The largest Fibrocell Science Inc. buyer in Q1 2014 was Third Security, an estimated $5.3M added.
  • The largest Fibrocell Science Inc. seller in Q1 2014 was Sabby Management, an estimated $363K sold.

Based on aggregated 13F filings for Q1 2014.